Corrigendum to "Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists" [Bioorg. Med. Chem. 22 (2014) 6071–6088]. Issue 13 (1st July 2015)